SCHEMBL6420522

SCHEMBL6420522

COCCOc1ccc2cc(C([NH])=O)c(=O)oc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 11/20 0.60
MAOA P21397 7/20 0.60
SLC16A3 O15427 3/20 0.56
ALDH1A1 P00352 5/20 0.55
GAA P10253 4/20 0.55
HPGD P15428 4/20 0.55
KDM4E B2RXH2 3/20 0.55
GLA P06280 3/20 0.55
HSD17B10 Q99714 2/20 0.55
CA12 O43570 1/20 0.53
CA2 P00918 1/20 0.53
CA3 P07451 1/20 0.53
CA4 P22748 1/20 0.53
CA6 P23280 1/20 0.53
CA7 P43166 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53
CYP2C19 P33261 1/20 0.53
RAB9A P51151 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6416333 0.90 MAOB (0.57) MAOBMAOAALDH1A1GAAHPGD
SCHEMBL30110285 0.89 MAOB (0.71) MAOBMAOASLC16A3ALDH1A1GAA
SCHEMBL6418716 0.89 SLC16A3 (0.71) MAOBMAOASLC16A3ALDH1A1GAA
SCHEMBL6420525 0.88 MAOB (0.60) MAOBMAOASLC16A3ALDH1A1GAA
SCHEMBL31206473 0.88 MAOB (0.60) MAOBMAOASLC16A3ALDH1A1GAA
SCHEMBL6420916 0.84 MAOB (0.76) MAOBMAOAALDH1A1GAAHPGD
SCHEMBL6416124 0.79 KDM4E (0.71) MAOBMAOASLC16A3ALDH1A1GAA
SCHEMBL6416335 0.78 MAOB (0.57) MAOBMAOAALDH1A1GAAHPGD
SCHEMBL16674827 0.77 MAOB (0.69) MAOBMAOASLC16A3ALDH1A1GAA
SCHEMBL28918549 0.77 MAOB (0.72) MAOBMAOASLC16A3ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005118584-A2 SAFRAMYCIN ANALOGS AS THERAPEUTIC AGENTS IN THE TREATMENT OF CANCER AXYS PHARMACEUTICALS, INC. (US) 2005-12-15 WO disclosed